{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:26:32Z","timestamp":1793226392831,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.biopsych.2004.10.019","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T18:44:54Z","timestamp":1104259494000},"page":"252-260","source":"Crossref","is-referenced-by-count":352,"title":["Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains"],"prefix":"10.1016","volume":"57","author":[{"given":"E. Fuller","family":"Torrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata M.","family":"Barci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree J.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Bartko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Meador-Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Knable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2004.10.019_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","article-title":"Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics","volume":"52","author":"Akbarian","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0920-9964(96)00122-3","article-title":"Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex in schizophrenics","volume":"24","author":"Beasley","year":"1997","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0006-3223(02)01360-4","article-title":"Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins","volume":"52","author":"Beasley","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-3956(96)00044-1","article-title":"The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia","volume":"31","author":"Benes","year":"1997","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","article-title":"GABAergic interneurons","volume":"25","author":"Benes","year":"2001","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2004.10.019_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0006-3223(98)00138-3","article-title":"A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives","volume":"44","author":"Benes","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/cercor\/2.6.503","article-title":"Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain","volume":"2","author":"Benes","year":"1992","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2004.10.019_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0891-0618(00)00105-8","article-title":"Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain","volume":"20","author":"Benes","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.biopsych.2004.10.019_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1098-2396(199701)25:1<80::AID-SYN10>3.0.CO;2-2","article-title":"Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain","volume":"25","author":"Benes","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2004.10.019_bib10","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archpsyc.1991.01810350036005","article-title":"Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients","volume":"48","author":"Benes","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S1461145702002894","article-title":"The GABAergic system in schizophrenia","volume":"5","author":"Blum","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2004.10.019_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00964333","article-title":"GABA metabolism in Venezuelan equine encephalomyelitis virus infection","volume":"5","author":"Bonila","year":"1980","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib13","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00001756-199906030-00022","article-title":"Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder","volume":"10","author":"Caberlotto","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2004.10.019_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/0929867043456034","article-title":"Schizophrenia","volume":"11","author":"Carlsson","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.biopsych.2004.10.019_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.npp.1300031","article-title":"Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine","volume":"28","author":"Cochran","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2004.10.019_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0006-3223(01)01243-4","article-title":"The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia","volume":"51","author":"Cotter","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4927(97)00071-1","article-title":"Schizophrenia and anterovental thalamic nucleus","volume":"82","author":"Danos","year":"1998","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/10298420290031432","article-title":"Neuropeptides involved in the pathophysiology of schizophrenia and major depression","volume":"4","author":"De Wied","year":"2002","journal-title":"Neurotox Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0306-4522(94)00586-T","article-title":"Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia","volume":"66","author":"Eastwood","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2004.10.019_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1192\/bjp.176.3.236","article-title":"Synaptophysin gene expression in schizophrenia","volume":"176","author":"Eastwood","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0306-4522(01)00141-5","article-title":"Cerebellar synaptic protein expression in schizophrenia","volume":"105","author":"Eastwood","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2004.10.019_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.mp.4000741","article-title":"Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression","volume":"5","author":"Eastwood","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0361-9230(01)00530-5","article-title":"Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins","volume":"55","author":"Eastwood","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2004.10.019_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0920-9964(03)80595-9","article-title":"Reelin mRNA is decreased in neurons of the hippocampus and temporal cortex in schizophrenia","volume":"60","author":"Eastwood","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.mp.4000238","article-title":"Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes","volume":"2","author":"Eastwood","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-9964(01)00299-7","article-title":"Neuronal calcium-binding proteins and schizophrenia","volume":"57","author":"Eyles","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.mp.4000783","article-title":"Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression","volume":"5","author":"Fatemi","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib28","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1097\/00001756-200110290-00023","article-title":"Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia","volume":"12","author":"Fatemi","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2004.10.019_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.mp.4000520","article-title":"Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice","volume":"4","author":"Fatemi","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2004.02.017","article-title":"GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum","volume":"72","author":"Fatemi","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib31","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1128\/JVI.74.8.3441-3448.2000","volume":"74","author":"Gonzalez-Dunia","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.biopsych.2004.10.019_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0022-3999(02)00426-9","article-title":"Signaling networks in the pathophysiology of mood disorders","volume":"53","author":"Gould","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/122.4.593","article-title":"The neuropathology of schizophrenia. A critical review of the data and their interpretation","volume":"122","author":"Harrison","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2004.10.019_bib35","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1523\/JNEUROSCI.23-15-06315.2003","article-title":"Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia","volume":"23","author":"Hashimoto","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2004.10.019_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.59.6.521","article-title":"Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia","volume":"59","author":"Heckers","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0074-7742(04)59007-4","article-title":"Presynaptic proteins and schizophrenia","volume":"59","author":"Honer","year":"2003","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.biopsych.2004.10.019_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1006\/jaut.1993.1044","article-title":"Coxsackievirus B4 alters pancreatic glutamate decarboxylase expression in mice soon after infection","volume":"6","author":"Hou","year":"1993","journal-title":"J Autoimmun"},{"key":"10.1016\/j.biopsych.2004.10.019_bib39","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.95.26.15718","article-title":"A decrease of reelin expression as a putative vulnerability factor in schizophrenia","volume":"95","author":"Impagnatiello","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2004.10.019_bib40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF00247314","article-title":"Dopamine function in the prefrontal cortex of the rat is sensitive to a reduction of tonic GABA-mediated inhibition in the thalamic mediodorsal nucleus","volume":"69","author":"Jones","year":"1988","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.mp.4001034","article-title":"Molecular abnormalities in the major psychiatric illnesses","volume":"7","author":"Knable","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1566-2772(02)00042-7","article-title":"Abnormalities of the cingulate gyrus in bipolar disorder and other severe psychiatric illnesses","volume":"2","author":"Knable","year":"2002","journal-title":"Clin Neurosci Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib43","series-title":"The Post-Mortem Brain in Psychiatric Research","first-page":"105","article-title":"Summary of prefrontal molecular abnormalities in the Stanley Foundation Neuropathology Consortium","author":"Knable","year":"2002"},{"key":"10.1016\/j.biopsych.2004.10.019_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.mp.4001471","article-title":"Molecular abnormalities of the hippocampus in severe psychiatric illness","volume":"9","author":"Knable","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(00)00174-2","article-title":"Low GSK-3 activity in frontal cortex of schizophrenic patients","volume":"52","author":"Kozlovsky","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/appi.ajp.157.5.831","article-title":"Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients","volume":"157","author":"Kozlovsky","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib47","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1176\/appi.ajp.158.9.1411","article-title":"Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia","volume":"158","author":"Lewis","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/1029842021000022089","article-title":"A neurodevelopmental model of schizophrenia","volume":"4","author":"Lipska","year":"2002","journal-title":"Neurotox Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biopsych.2003.09.017","article-title":"Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia","volume":"55","author":"L\u00f3pez-Figueroa","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1471-4159.1993.tb03165.x","article-title":"Regulation of gamma-aminobutyric acid synthesis in the brain","volume":"60","author":"Martin","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2004.10.019_bib51","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00005072-199211000-00003","article-title":"Selective neuronal vulnerability in HIV encephalitis","volume":"51","author":"Masliah","year":"1992","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.biopsych.2004.10.019_bib52","first-page":"285","article-title":"Cortical dendritic pathology in human immunodeficiency virus encephalitis","volume":"66","author":"Masliah","year":"1992","journal-title":"Lab Invest"},{"key":"10.1016\/j.biopsych.2004.10.019_bib53","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2144\/04364ST03","article-title":"Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue","volume":"36","author":"Miller","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.biopsych.2004.10.019_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0896-6273(00)00085-4","article-title":"Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex","volume":"28","author":"Mirnics","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2004.10.019_bib55","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1523\/JNEUROSCI.16-01-00220.1996","article-title":"Persistent dentate granule cell hyperexcitability after neonatal infection with lymphocytic choriomeningitis virus","volume":"16","author":"Pearce","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2004.10.019_bib57","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s007020200072","article-title":"Understanding the neurotransmitter pathology of schizophrenia","volume":"109","author":"Reynolds","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.biopsych.2004.10.019_bib58","first-page":"119","article-title":"Chronic antipsychotic drug administration alters calcium-binding protein levels but not GAD levels in the prefrontal cortex of the rat","volume":"36","author":"Scruggs","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0920-9964(03)80583-2","article-title":"Reduction of GAD-67 mRNA in the striatum of patients with schizophrenia and bipolar disorder","volume":"60","author":"Shannon-Weickert","year":"2003","journal-title":"Schizophr Res"},{"issue":"suppl 37","key":"10.1016\/j.biopsych.2004.10.019_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/S0007125000293598","article-title":"Glutamatergic aspects of schizophrenia","volume":"174","author":"Tamminga","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S0033291702006876","article-title":"GABA and mood disorders","volume":"33","author":"Taylor","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2004.10.019_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/(SICI)1098-2396(199808)29:4<323::AID-SYN4>3.0.CO;2-7","article-title":"Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain","volume":"29","author":"Todtenkopf","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2004.10.019_bib63","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.biopsych.2003.10.013","article-title":"Effect of agonal and postmortem factors on gene expression profile","volume":"55","author":"Tomita","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(99)00107-3","article-title":"Epidemiological comparison of schizophrenia and bipolar disorder","volume":"39","author":"Torrey","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0920-9964(99)00104-8","article-title":"Are schizophrenia and bipolar disorder one disease or two?","volume":"39","author":"Torrey","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-9964(99)00192-9","article-title":"The Stanley Foundation brain collection and Neuropathology Consortium","volume":"44","author":"Torrey","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.mp.4001158","article-title":"Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia","volume":"7","author":"Vawter","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/syn.890170104","article-title":"The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex","volume":"17","author":"Vincent","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2004.10.019_bib69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archpsyc.57.3.237","article-title":"Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia","volume":"57","author":"Volk","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib70","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.jcp.0000095349.32154.a5","article-title":"GABA and schizophrenia","volume":"23","author":"Wassef","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2004.10.019_bib71","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.mp.4001139","article-title":"Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders","volume":"7","author":"Webster","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0920-9964(00)00052-9","article-title":"Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia","volume":"49","author":"Webster","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.10.019_bib73","series-title":"Statistical Principles in Experimental Design","first-page":"165","author":"Winer","year":"1991"},{"key":"10.1016\/j.biopsych.2004.10.019_bib74","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1176\/ajp.154.7.1013","article-title":"Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons","volume":"154","author":"Woo","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.10.019_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00188-8","article-title":"A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia","volume":"55","author":"Zhang","year":"2002","journal-title":"Schizophr Res"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322304010996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322304010996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T10:25:56Z","timestamp":1548843956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322304010996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0006322304010996"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2004.10.019","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}